4th Quarter - Report

MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Firm
Client
Income
—
Expenses
$270,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H. Con. Res. 112, Establishing the budget for the US Government for FY 2013. H.R. 5973/S. 2375, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2013. H. J. Res. 117, Continuing Appropriations Resolution, 2013.

LobbyistCovered position, as disclosed
AARTI SHAH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 112 (112th), H.J.Res. 117 (112th), H.R. 5973 (112th), S. 2375 (112th)

Medicare/Medicaid MMM

Medicare coverage and reimbursement. H. Con. Res 112, Establishing the budget for the US Government for FY 2013. H.R. 6684, Spending Reduction Act of 2012. H.R. 8, American Taxpayer Relief Act of 2012.

LobbyistCovered position, as disclosed
AARTI SHAH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.Con.Res. 112 (112th), H.R. 6684 (112th), H.R. 8 (112th)

Health Issues HCR

340B-related issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation).

LobbyistCovered position, as disclosed
AARTI SHAH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. H.R. 6433, FDA User Fee Corrections Act of 2012.

LobbyistCovered position, as disclosed
AARTI SHAH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5651 (112th), S. 2516 (112th), H.R. 6433 (112th), S. 2292 (112th), S. 3187 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.